Thank you very much.
One of your members is 3M, and in London, Ontario, 3M is a very important company. They employ 800 people. I think about what this proposed measure would entail for them from a cost perspective, in particular, as well as for many other companies, not to mention only 3M.
I heard you say in your testimony that there's no clearly defined benefit that's been articulated to you. The organization engaged on this with officials from Health Canada, I believe. Is that correct?